| その他の名称： | (6R,6aR,6a'R,7S,7'S,8R,8'R,9S,9'S,10S,10'S,10aS,10a'S)-6,6',6a,6a',7,7',8,8',9,9',10,10'-Dodecahydro-1',5,8,8',10',10a,10a',12,12'-nonahydroxy-7,7'-bis(2,6-dideoxy-α-D-ribo-hexopyranosyloxy)-9-[4-O-(3,4-dihydroxy-4-acetyl-5-methyltetrahydro-2H-pyran-2-yl)-2,3,6-trideoxy-β-L-erythro-hexopyranosyloxy]-9'-(2,3,6-trideoxy-β-L-erythro-hexopyranosyloxy)-3,3',4'-trimethoxy-10,10'-dipropyl-6,10-epoxy-2,2'-binaphthacene-1,4,11,11'(10aH,10a'H)-tetrone、ヒバリミシンI、Hibarimicin I |
| 体系名： | (6R,6aR,6a'R,7S,7'S,8R,8'R,9S,9'S,10S,10'S,10aS,10a'S)-6,6',6a,6a',7,7',8,8',9,9',10,10'-ドデカヒドロ-1',5,8,8',10',10a,10a',12,12'-ノナヒドロキシ-7,7'-ビス(2,6-ジデオキシ-α-D-ribo-ヘキソピラノシルオキシ)-9-[4-O-(3,4-ジヒドロキシ-4-アセチル-5-メチルテトラヒドロ-2H-ピラン-2-イル)-2,3,6-トリデオキシ-β-L-erythro-ヘキソピラノシルオキシ]-9'-(2,3,6-トリデオキシ-β-L-erythro-ヘキソピラノシルオキシ)-3,3',4'-トリメトキシ-10,10'-ジプロピル-6,10-エポキシ-2,2'-ビナフタセン-1,4,11,11'(10aH,10a'H)-テトラオン |
